These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 4196288)
1. Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Halstead SB; Casals J; Shotwell H; Palumbo N Am J Trop Med Hyg; 1973 May; 22(3):365-74. PubMed ID: 4196288 [No Abstract] [Full Text] [Related]
2. Studies on the immunization of monkeys against dengue. II. Protection following inoculation of combinations of viruses. Halstead SB; Palumbo NE Am J Trop Med Hyg; 1973 May; 22(3):375-81. PubMed ID: 4196289 [No Abstract] [Full Text] [Related]
3. The attenuation of the 26th mouse brain passage of New Guinea C strain of dengue 2 virus for use in the sequential immunization procedure against group B arboviruses. Price WH; Thind IS; O'Leary W Am J Trop Med Hyg; 1973 Jan; 22(1):92-9. PubMed ID: 4630883 [No Abstract] [Full Text] [Related]
4. Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate). Price WH; Casals J; Thind I; O'Leary W Am J Trop Med Hyg; 1973 Jul; 22(4):509-23. PubMed ID: 4352231 [No Abstract] [Full Text] [Related]
5. Studies on the sequential immunization against group B arboviruses in squirrel monkeys, cynomolgus monkeys, rhesus monkeys, and chimpanzees. Price WH; Casals J; O'Leary W Am J Trop Med Hyg; 1974 Jan; 23(1):118-30. PubMed ID: 4204022 [No Abstract] [Full Text] [Related]
6. Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. Halstead SB; Shotwell H; Casals J J Infect Dis; 1973 Jul; 128(1):7-14. PubMed ID: 4198027 [No Abstract] [Full Text] [Related]
7. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509 [TBL] [Abstract][Full Text] [Related]
8. Blood value changes in flavivirus-inoculated Macaca fascicularis monkeys. Angsubhakorn S; Yoksan S; Henchal EA; Nisalak A; Hoke CH; Pradermwong A; Sahaphong S; Bhamarapravati N Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):1-7. PubMed ID: 2874612 [TBL] [Abstract][Full Text] [Related]
9. Neurovirulence detection of dengue virus using rhesus and cynomolgus monkeys. Angsubhakorn S; Moe JB; Marchette NJ; Latendresse JR; Palumbo NE; Yoksan S; Bhamarapravati N J Virol Methods; 1987 Oct; 18(1):13-24. PubMed ID: 3693516 [TBL] [Abstract][Full Text] [Related]
10. Dengue type 3 infection in Panama. Rosen L Am J Trop Med Hyg; 1974 Nov; 23(6):1205-6. PubMed ID: 4429191 [No Abstract] [Full Text] [Related]
11. Cross-protection studies and search for subclinical disease in new world monkeys infected sequentially with different immunologic types of Dengue viruses. Scherer WF; Breakenridge FA; Dickerman RW Am J Epidemiol; 1972 Jan; 95(1):67-79. PubMed ID: 4621395 [No Abstract] [Full Text] [Related]
13. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852 [TBL] [Abstract][Full Text] [Related]
14. Dengue-4 vaccine: neurovirulence, viraemia and immune responses in rhesus and cynomolgus monkeys. Angsubhakorn S; Yoksan S; Bhamarapravati N; Moe JB; Marchette NJ; Pradermwong A; Sahaphong S Trans R Soc Trop Med Hyg; 1988; 82(5):746-9. PubMed ID: 3252595 [TBL] [Abstract][Full Text] [Related]
15. TWO EPISODES OF DENGUE FEVER, CAUSED BY TYPES 4 AND 1 VIRUSES, IN AN INDIVIDUAL PREVIOUSLY IMMUNIZED AGAINST YELLOW FEVER. CAREY DE; MYERS RM; RODRIGUES FM Am J Trop Med Hyg; 1965 May; 14():448-50. PubMed ID: 14292751 [No Abstract] [Full Text] [Related]
16. Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status. Scott RM; Eckels KH; Bancroft WH; Summers PL; McCown JM; Anderson JH; Russell PK J Infect Dis; 1983 Dec; 148(6):1055-60. PubMed ID: 6655288 [TBL] [Abstract][Full Text] [Related]
17. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771 [TBL] [Abstract][Full Text] [Related]
18. Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys. Butrapet S; Rabablert J; Angsubhakorn S; Wiriyarat W; Huang C; Kinney R; Punyim S; Bhamarapravati N Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):589-99. PubMed ID: 12693596 [TBL] [Abstract][Full Text] [Related]
19. The 1968 outbreak of dengue in Vellore, Southern India. Myers RM; Varkey MJ; Reuben R; Jesudass ES; Benjamin B Am J Public Health; 1971 Jul; 61(7):1379-91. PubMed ID: 4998174 [No Abstract] [Full Text] [Related]
20. Research on dengue in tissue culture. V. Production of anti-dengue antibodies in tissue cultures from monkeys inoculated with an attenuated type I dengue virus strain. Fujita N; Izaki S; Oda K; Kimura E; Hotta S Kobe J Med Sci; 1972 Sep; 18(3):143-52. PubMed ID: 4200059 [No Abstract] [Full Text] [Related] [Next] [New Search]